Effect of extracorporeal shockwave therapy on muscle spasticity in patients with cerebral palsy
محل انتشار: نوزدهمین کنگره سالانه اعصاب کودکان ایران
سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 168
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
CCNMED19_046
تاریخ نمایه سازی: 28 شهریور 1401
چکیده مقاله:
Introduction: Recently, clinical trials have been performed to evaluate the efficacy of extracorporeal shockwave therapy (ESWT) in patients with cerebral palsy (CP).However, various studies adopted different clinical scales, making it insufficient to draw a definite conclusion about the efficacy of ESWT in reducing spasticity after cerebralpalsy. The purpose of this meta-analysis was to assess the effects of ESWT on reducing spasticity after applying ESWT in patients with CP. Evidence Acquisition: In accordance with the PRISMA statement, authors searched Medline, Embase, Web of Science, Cochrane Central Register of Controlled Trials and Scopus from their inception dates through December ۱۱th ۲۰۱۸. We included randomised controlled trials in any language that using ESWT for the purpose of ameliorating spasticity in patients with CP. We assessed spasticity measured by modified Ashworth Scale (MAS), range of motion (ROM) and baropodometric values as outcomes. Evidence Synthesis: Two authors independently extracted and verified data. Metaanalysis was completed where possible, otherwise data were synthesised narratively. From a total of ۲۰۶ articles, ۱۶ manuscripts were selected and ۵ of them were ultimately included in this meta-analysis. MAS grade as primary outcome was significantly improved after ESWT compared to that in the control group (mean difference [MD]:- ۰.۶۲; ۹۵% CI:-۱.۵۲ to -۰.۱۸). ROM after ESWT was also significantly improved compared to that in the control groups (MD:۱۸.۰۱; ۹۵% CI:۶.۱۱ to ۲۹.۹۱). Baropodometric measures showed significantly increases in foot contact area during gait (SMD:۲۹.۰۰; ۹۵% CI:۱۱.۰۸ to ۴۶.۹۲), but not significantly in peak pressure nder the heel (MD:۱۵.۱۲; ۹۵% CI:-۱.۸۵ to ۳۲.۱۰) immediately after ESWT. Conclusions: No serious side effects were observed in any patient after ESWT. ESWT may be a valid alternative to existing treatment options targeting spasticity diminishment and ROM improvement in CP patients to maintain healthy lifestyles and normalize spastic gait pattern. Further standardization of treatment protocols including treatment intervals and intensities needs to be established and long-term follow-up studies areneeded to verify our results.
کلیدواژه ها:
نویسندگان
Hadi Sarafraz
PhD, Physiotherapy, Department of Occupational Medicine, Shahid Mohammadi Hospital, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
Mohsen Razeghi
Associate Professor, Physiotherapy, Rehabilitation Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Mohammad Reza Hadian Rasnani
Professor, Physiotherapy, Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran